Full Product Details
Author: Maureen D. Mayes
Publisher: Springer-Verlag New York Inc.
Imprint: Springer-Verlag New York Inc.
Edition: Softcover reprint of the original 1st ed. 2014
Weight: 2.291kg
ISBN: 9781493945023
ISBN 10: 1493945025
Pages: 114
Publication Date: 03 September 2016
Audience:
Professional and scholarly
,
Professional & Vocational
Format: Paperback
Publisher's Status: Active
Availability: Manufactured on demand
We will order this item for you from a manufactured on demand supplier.
Reviews
From the book reviews: With many illustrations, this book presents clinical manifestations of scleroderma at various stages to help healthcare providers understand the disease. ... The audience includes residents, fellows, and physicians ... . This book is well written and well illustrated, easy to read and very informative about scleroderma. (Eun Joo Park, Doody's Book Reviews, October, 2014)
From the book reviews: “With many illustrations, this book presents clinical manifestations of scleroderma at various stages to help healthcare providers understand the disease. … The audience includes residents, fellows, and physicians … . This book is well written and well illustrated, easy to read and very informative about scleroderma.” (Eun Joo Park, Doody’s Book Reviews, October, 2014)
From the book reviews: With many illustrations, this book presents clinical manifestations of scleroderma at various stages to help healthcare providers understand the disease. ... The audience includes residents, fellows, and physicians ... . This book is well written and well illustrated, easy to read and very informative about scleroderma. (Eun Joo Park, Doody's Book Reviews, October, 2014)
Author Information
Maureen D. Mayes is a rheumatologist and Professor of Medicine in the Division of Rheumatology and Clinical Immunogenetics at the University of Texas-Houston Medical School where she directs the Scleroderma Clinic. She is currently the Principal Investigator of the NIH/NIAMS funded ‘Scleroderma Family Registry and DNA Repository’ and is author of more than 80 publications relating to scleroderma, its complications and its treatment. Dr. Mayes obtained her Masters of Public Health at the University of Michigan where she studied the epidemiology of scleroderma, resulting in a comprehensive analysis of the prevalence, incidence and survival of this disease. As Principal Investigator of the Scleroderma Family Registry and DNA Repository, she is currently studying the role of genetic factors in scleroderma susceptibility and disease severity. Dr. Mayes also conducts clinical treatment trials in scleroderma, both NIH and industry sponsored.
